Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Psychiatry
•
Geriatric Psychiatry
•
Behavioral Neurology & Neuropsychiatry
•
Dementia
What are the limits and standalone value of volumetric MRI for the preclinical evaluation of dementia?
E.g. patient with family history of Alzheimer's but no symptoms themselves currently
Related Questions
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
How do you manage sleep disturbances in patients with Alzheimer’s disease without relying heavily on deliriogenic medications?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
How do you approach evaluating sudden mental status changes in telepsychiatry patients, particularly older adults, when medical causes such as infection or metabolic disturbance may be contributing factors?
How do you treat agitation in progressive supranuclear palsy?
When is it useful to test for multiple amyloid-related biomarkers for patients underoing work-up for cognitive impairment?
How do you manage problematic disinhibited behaviors in patients with neurocognitive disorders?
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
What would be your approach to the consideration of the use of antiamyloid monoclonal antibodies for nonamnestic Alzheimer's disease with a positive biomarker for brain amyloid pathology?
Is there sufficient evidence yet to support the use of lithium supplementation or prescription in the management of neurodegenerative diseases?